Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001641172-25-020071
Filing Date
2025-07-17
Accepted
2025-07-17 16:56:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5608
  Complete submission text file 0001641172-25-020071.txt   7223
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Subject) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92761 | Film No.: 251131274
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SPERLRING 2 PFAFFENHOFEN 2M 85276
Business Address SPERLRING 2 PFAFFENHOFEN 2M 85276 498441 78644 14
Orca Capital AG (Filed by) CIK: 0002052389 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SCHEDULE 13G